Multiple-dose trial of EVT 201 in China

Trial Profile

Multiple-dose trial of EVT 201 in China

Phase of Trial: Phase I

Latest Information Update: 30 Mar 2015

At a glance

  • Drugs EVT 201 (Primary)
  • Indications Insomnia
  • Focus Adverse reactions
  • Sponsors Zhejiang Jingxin Pharmaceutical
  • Most Recent Events

    • 30 Mar 2015 New trial record
    • 24 Mar 2015 This multiple-dose study was initiated in 2014 by JingXin Pharmaceutical, according to an Evotec media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top